A 52-year-old woman from Delhi presents with severe, burning pain in the left T5 dermatome for 3 days, followed by grouped vesicles on an erythematous base. She is otherwise healthy with no immunosuppression. Which finding would best distinguish this presentation from recurrent herpes simplex infection at an unusual site?

Explanation

## Clinical Distinction: Zoster vs. Atypical HSV ### The Clinical Scenario This patient presents with: - Dermatomal pain prodrome (3 days) - Grouped vesicles on erythematous base - Unilateral, band-like distribution (T5 dermatome) - Immunocompetent status The question asks: which feature **clinically distinguishes** this from HSV at an unusual site? ### Key Discriminating Feature **Key Point:** Unilateral dermatomal distribution with sharp midline demarcation is the cardinal clinical sign that distinguishes zoster from HSV, which presents in random, non-dermatomal patterns. ### Comparison of Distinguishing Features | Feature | Zoster | Recurrent HSV | | --- | --- | --- | | **Distribution pattern** | Strict dermatomal (unilateral, follows nerve root) | Random sites; no dermatomal pattern | | **Midline demarcation** | Sharp, respects midline | No midline boundary | | **Post-herpetic neuralgia (PHN)** | Common (>50% in age >50 years) | Rare or absent | | **Pain prodrome** | Present (1–3 days) | May occur but less prominent | | **Viral PCR** | Positive for VZV | Positive for HSV-1 or HSV-2 | | **Recurrence rate** | <5% in immunocompetent | >50% in recurrent HSV | ### Why Dermatomal Distribution Is the Best Bedside Discriminator **High-Yield:** The dermatomal pattern is: 1. **Clinically evident** — no lab test needed; visible on inspection 2. **Anatomically specific** — reflects the affected sensory ganglion 3. **Pathognomonic for zoster** — HSV does not respect dermatomes 4. **Immediate** — recognized at presentation, before complications or serology **Clinical Pearl:** The sharp midline demarcation (lesions do not cross the midline) is a direct consequence of the dermatomal distribution and is virtually pathognomonic for zoster. ### Why Other Options Are Not the Best Discriminator **Option 0 (PHN):** Post-herpetic neuralgia is a **complication** that develops *after* rash resolution and is not present at the time of diagnosis. While PHN is more common in zoster than HSV, it cannot be used to distinguish at presentation. **Option 2 (PCR for VZV):** PCR is **confirmatory** but requires laboratory processing and does not distinguish clinically. A bedside discriminator is more valuable in acute care. **Option 3 (Pain preceding rash):** Both zoster and HSV can present with pain prodrome. While zoster prodrome is often more severe and dermatomal, HSV can also have burning pain at the site. This feature alone is not discriminating.